
TY  - JOUR
C7  - e13424
TI  - Poster Communications
JO  - Acta Physiologica
JA  - Acta Physiol
VL  - 227
IS  - S722
SN  - 1748-1708
UR  - https://doi.org/10.1111/apha.13424
DO  - doi:10.1111/apha.13424
SP  - e13424
PY  - 2019
ER  - 

TY  - JOUR
TI  - Plenary Lectures and Symposia A1
JO  - Clinical and Experimental Pharmacology and Physiology
VL  - 31
IS  - s1
SN  - 0305-1870
UR  - https://doi.org/10.1111/j.1440-1681.2004.cep_4026.pdf.x
DO  - doi:10.1111/j.1440-1681.2004.cep_4026.pdf.x
SP  - A1
EP  - A50
PY  - 2004
ER  - 

TY  - JOUR
TI  - 2013 Annual Meeting Abstract Supplement
JO  - Arthritis & Rheumatism
JA  - Arthritis & Rheumatism
VL  - 65
IS  - S10
SN  - 0004-3591
UR  - https://doi.org/10.1002/art.38216
DO  - doi:10.1002/art.38216
SP  - S1
EP  - S1331
PY  - 2013
ER  - 

TY  - JOUR
TI  - Abstracts from the 10th World Congress for Microcirculation
JO  - Microcirculation
JA  - Microcirculation
VL  - 22
IS  - 7
SN  - 1073-9688
UR  - https://doi.org/10.1111/micc.12246
DO  - doi:10.1111/micc.12246
SP  - 542
EP  - 676
PY  - 2015
ER  - 

TY  - JOUR
AU  - Horan, Martin
AU  - Millar, David S.
AU  - Hedderich, Jürgen
AU  - Lewis, Geraint
AU  - Newsway, Vicky
AU  - Mo, Neil
AU  - Fryklund, Linda
AU  - Procter, Annie M.
AU  - Krawczak, Michael
AU  - Cooper, David N.
TI  - Human growth hormone 1 (GH1) gene expression: Complex haplotype-dependent influence of polymorphic variation in the proximal promoter and locus control region
JO  - Human Mutation
JA  - Hum. Mutat.
VL  - 21
IS  - 4
SN  - 1059-7794
UR  - https://doi.org/10.1002/humu.10167
DO  - doi:10.1002/humu.10167
SP  - 408
EP  - 423
KW  - growth hormone
KW  - GH1
KW  - promoter
KW  - polymorphism
KW  - SNP
KW  - haplotypes
KW  - expression
KW  - transcription factor binding
KW  - haplotype partitioning
KW  - locus control region
KW  - short stature
KW  - linkage disequilibrium
KW  - evolution
PY  - 2003
AB  - Abstract The proximal promoter region of the human pituitary expressed growth hormone (GH1) gene is highly polymorphic, containing at least 15 single nucleotide polymorphisms (SNPs). This variation is manifest in 40 different haplotypes, the high diversity being explicable in terms of gene conversion, recurrent mutation, and selection. Functional analysis showed that 12 haplotypes were associated with a significantly reduced level of reporter gene expression whereas 10 haplotypes were associated with a significantly increased level. The former tend to be more prevalent in the general population than the latter (p<0.01), possibly as a consequence of selection. Although individual SNPs contributed to promoter strength in a highly interactive and non-additive fashion, haplotype partitioning was successful in identifying six SNPs as major determinants of GH1 gene expression. The prediction and functional testing of hitherto unobserved super-maximal and sub-minimal promoter haplotypes was then used to test the efficacy of the haplotype partitioning approach. Electrophoretic mobility shift assays demonstrated that five SNP sites exhibit allele-specific protein binding. An association was noted between adult height and the mean in vitro expression value corresponding to an individual's GH1 promoter haplotype combination (p=0.028) although only 3.3% of the variance of adult height was found to be explicable by reference to this parameter. Three additional SNPs, identified within sites I and II of the upstream locus control region (LCR), were ascribed to three distinct LCR haplotypes. A series of LCR-GH1 proximal promoter constructs were used to demonstrate that 1) the LCR enhanced proximal promoter activity by up to 2.8-fold depending upon proximal promoter haplotype, and that 2) the activity of a given proximal promoter haplotype was also differentially enhanced by different LCR haplotypes. The genetic basis of inter-individual differences in GH1 gene expression thus appears to be extremely complex. Hum Mutat 21:408?423, 2003. ? 2003 Wiley-Liss, Inc.
ER  - 

TY  - JOUR
TI  - Abstracts of the Fourteenth International Congress of Parkinson's Disease and Movement Disorders
JO  - Movement Disorders
JA  - Mov. Disord.
VL  - 25
IS  - S2
SN  - 0885-3185
UR  - https://doi.org/10.1002/mds.23162
DO  - doi:10.1002/mds.23162
SP  - S181
EP  - S565
PY  - 2010
ER  - 

TY  - JOUR
TI  - Posters (Abstracts 289–2348)
JO  - Hepatology
JA  - Hepatology
VL  - 70
IS  - S1
SN  - 0270-9139
UR  - https://doi.org/10.1002/hep.30941
DO  - doi:10.1002/hep.30941
SP  - 188
EP  - 1382
PY  - 2019
ER  - 

TY  - JOUR
TI  - Abstracts
JO  - Developmental Medicine & Child Neurology
VL  - 53
IS  - s3
SN  - 0012-1622
UR  - https://doi.org/10.1111/j.1469-8749.2011.04011.x
DO  - doi:10.1111/j.1469-8749.2011.04011.x
SP  - 3
EP  - 12
PY  - 2011
ER  - 

TY  - JOUR
TI  - POSTER SESSION: BASIC SCIENCE
JO  - European Journal of Heart Failure
JA  - European Journal of Heart Failure
VL  - 12
IS  - S1
SN  - 1388-9842
UR  - https://doi.org/10.1093/eurjhf/hst008
DO  - doi:10.1093/eurjhf/hst008
SP  - S36
EP  - S72
PY  - 2013
ER  - 

TY  - JOUR
TI  - Workshops
JO  - European Journal of Clinical Investigation
JA  - Eur J Clin Invest
VL  - 46
IS  - S1
SN  - 0014-2972
UR  - https://doi.org/10.1111/eci.12604
DO  - doi:10.1111/eci.12604
SP  - 6
EP  - 119
PY  - 2016
ER  - 

TY  - JOUR
TI  - Poster Abstracts
JO  - Colorectal Disease
JA  - Colorectal Dis
VL  - 18
IS  - S1
SN  - 1462-8910
UR  - https://doi.org/10.1111/codi.13445
DO  - doi:10.1111/codi.13445
SP  - 44
EP  - 125
PY  - 2016
ER  - 

TY  - JOUR
TI  - Posters: Basic and clinical science posters: Beta-cells and islets
JO  - Diabetic Medicine
VL  - 27
IS  - s1
SN  - 0742-3071
UR  - https://doi.org/10.1111/j.1464-5491.2009.02936.x
DO  - doi:10.1111/j.1464-5491.2009.02936.x
SP  - 37
EP  - 188
PY  - 2010
ER  - 

C7  - pp. 599-625
TI  - Index
SN  - 9780470410301
UR  - https://doi.org/10.1002/9780470640500.index
DO  - doi:10.1002/9780470640500.index
SP  - 599-625
PY  - 2010
ER  - 

TY  - JOUR
TI  - Poster Presentations
JO  - The FEBS Journal
VL  - 278
IS  - s1
SN  - 9780470410301
UR  - https://doi.org/10.1111/j.1742-4658.2011.08137.x
DO  - doi:10.1111/j.1742-4658.2011.08137.x
SP  - 74
EP  - 445
PY  - 2011
ER  - 

TY  - JOUR
TI  - Poster Abstract
JO  - European Journal of Clinical Investigation
JA  - Eur J Clin Invest
VL  - 48
IS  - S1
SN  - 9780470410301
UR  - https://doi.org/10.1111/eci.12926
DO  - doi:10.1111/eci.12926
SP  - 70
EP  - 225
PY  - 2018
ER  - 

TY  - JOUR
TI  - Abstract
JO  - Journal of Thrombosis and Haemostasis
JA  - Journal of Thrombosis and Haemostasis
VL  - 5
IS  - S2
SN  - 9780470410301
UR  - https://doi.org/10.1111/j.1538-7836.2007.tb00035.x
DO  - doi:10.1111/j.1538-7836.2007.tb00035.x
SP  - P-W-401
EP  - P-W-701
PY  - 2007
ER  - 

TY  - JOUR
C7  - 19856
TI  - 2nd World Parkinson Congress Abstracts
JO  - Journal of the International AIDS Society
JA  - Mov. Disord.
VL  - 17
IS  - 4S3
SN  - 9780470410301
UR  - https://doi.org/10.7448/IAS.17.4.19856
DO  - doi:10.7448/IAS.17.4.19856
SP  - 19856
PY  - 2014
ER  - 

TY  - JOUR
TI  - Annual meeting program, lecture abstracts, symposium abstracts, workshop abstracts, platform session abstracts, poster session abstracts, author index, nbts program, code of ethics, society guidelines
JO  - Movement Disorders
JA  - Birth Defects Research Part A: Clinical and Molecular Teratology
VL  - 25
IS  - S3
SN  - 9780470410301
UR  - https://doi.org/10.1002/mds.23386
DO  - doi:10.1002/mds.23386
SP  - S569
EP  - S717
PY  - 2010
ER  - 

TY  - JOUR
TI  - Environmental impacts on the genome and epigenome: Mechanisms and risks, October 15–19, 2011
JO  - Birth Defects Research Part A: Clinical and Molecular Teratology
JA  - Environ. Mol. Mutagen.
VL  - 100
IS  - 5
SN  - 9780470410301
UR  - https://doi.org/10.1002/bdra.23251
DO  - doi:10.1002/bdra.23251
SP  - 319
EP  - 452
PY  - 2014
ER  - 

TY  - JOUR
TI  - Environmental impacts on the genome and epigenome: Mechanisms and risks, October 15–19, 2011
JO  - Environmental and Molecular Mutagenesis
VL  - 52
IS  - S1
SN  - 9780470410301
UR  - https://doi.org/10.1002/em.20693
DO  - doi:10.1002/em.20693
SP  - S1
EP  - S87
PY  - 2011
ER  - 
